Yakob Liawatidewi
Known title: EVP Corp Admin CenterCIK: 0001743927
Associated companies
Transaction History
| AMPH | ▼ Sell | Tax Withholding | 1,033 | $19K | 3/15/2026 | View on chart |
| AMPH | ▼ Sell | Tax Withholding | 1,870 | $35K | 3/10/2026 | View on chart |
| AMPH | ▲ Buy | Grant | 35,450 | $0 | 3/9/2026 | View on chart |
| AMPH | ▼ Sell | Tax Withholding | 1,144 | $22K | 3/6/2026 | View on chart |
| AMPH | ▼ Sell | Tax Withholding | 965 | $19K | 3/4/2026 | View on chart |
| AMPH | ▼ Sell | Tax Withholding | 1,731 | $48K | 3/17/2025 | View on chart |
| AMPH | ▼ Sell | Tax Withholding | 1,031 | $27K | 3/15/2025 | View on chart |
| AMPH | ▲ Buy | Grant | 20,837 | $0 | 3/10/2025 | View on chart |
| AMPH | ▼ Sell | Tax Withholding | 1,141 | $32K | 3/6/2025 | View on chart |
| AMPH | ▼ Sell | Tax Withholding | 963 | $27K | 3/4/2025 | View on chart |
| AMPH | ▲ Buy | Option Exercise | 5,214 | $68K | 11/6/2024 | View on chart |
| AMPH | ▼ Sell | Open Market | 5,214 | $271K | 11/6/2024 | View on chart |
| AMPH | ▼ Sell | Tax Withholding | 272 | $11K | 6/4/2024 | View on chart |
| AMPH | ▼ Sell | Tax Withholding | 1,726 | $74K | 3/17/2024 | View on chart |
| AMPH | ▼ Sell | Tax Withholding | 1,671 | $72K | 3/16/2024 | View on chart |
| AMPH | ▼ Sell | Tax Withholding | 1,027 | $44K | 3/15/2024 | View on chart |
| AMPH | ▼ Sell | Tax Withholding | 1,221 | $57K | 3/6/2024 | View on chart |
| AMPH | ▲ Buy | Grant | 10,754 | $0 | 3/4/2024 | View on chart |
| AMPH | ▲ Buy | Option Exercise | 3,319 | $56K | 8/28/2023 | View on chart |
| AMPH | ▲ Buy | Option Exercise | 5,497 | $111K | 8/28/2023 | View on chart |
| AMPH | ▲ Buy | Option Exercise | 20,000 | $261K | 8/28/2023 | View on chart |
| AMPH | ▼ Sell | Open Market | 28,816 | $1.5M | 8/28/2023 | View on chart |
| AMPH | ▼ Sell | Tax Withholding | 378 | $18K | 6/4/2023 | View on chart |
| AMPH | ▲ Buy | Option Exercise | 11,494 | $233K | 4/13/2023 | View on chart |
| AMPH | ▼ Sell | Open Market | 5,000 | $205K | 4/13/2023 | View on chart |
| AMPH | ▼ Sell | Open Market | 6,494 | $273K | 4/13/2023 | View on chart |
| AMPH | ▲ Buy | Option Exercise | 5,000 | $101K | 4/10/2023 | View on chart |
| AMPH | ▼ Sell | Open Market | 5,000 | $200K | 4/10/2023 | View on chart |
| AMPH | ▼ Sell | Tax Withholding | 1,673 | $61K | 3/17/2023 | View on chart |
| AMPH | ▼ Sell | Tax Withholding | 1,620 | $61K | 3/16/2023 | View on chart |
| AMPH | ▼ Sell | Tax Withholding | 1,851 | $68K | 3/15/2023 | View on chart |
| AMPH | ▲ Buy | Grant | 12,752 | $0 | 3/6/2023 | View on chart |
| AMPH | ▲ Buy | Option Exercise | 3,055 | $60K | 8/9/2022 | View on chart |
| AMPH | ▼ Sell | Open Market | 3,055 | $119K | 8/9/2022 | View on chart |
| AMPH | ▲ Buy | Option Exercise | 5,000 | $99K | 8/8/2022 | View on chart |
| AMPH | ▼ Sell | Open Market | 5,000 | $190K | 8/8/2022 | View on chart |
| AMPH | ▲ Buy | Option Exercise | 10,837 | $214K | 7/15/2022 | View on chart |
| AMPH | ▼ Sell | Open Market | 3,478 | $125K | 7/15/2022 | View on chart |
| AMPH | ▼ Sell | Open Market | 7,359 | $272K | 7/15/2022 | View on chart |
| AMPH | ▼ Sell | Tax Withholding | 128 | $4K | 6/14/2022 | View on chart |
| AMPH | ▼ Sell | Tax Withholding | 264 | $10K | 6/4/2022 | View on chart |
| AMPH | ▼ Sell | Tax Withholding | 1,673 | $57K | 3/17/2022 | View on chart |
| AMPH | ▼ Sell | Tax Withholding | 1,619 | $55K | 3/16/2022 | View on chart |
| AMPH | ▲ Buy | Grant | 11,514 | $0 | 3/15/2022 | View on chart |
| AMPH | ▼ Sell | Tax Withholding | 1,559 | $54K | 3/15/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 15, 2026
Amphastar (AMPH) Cited as Safe-and-Steady Stock in Yahoo Analysis
A recent Yahoo Finance article highlighted Amphastar Pharmaceuticals as a 'safe-and-steady' stock worth researching further. This positive framing contrasts with other companies facing challenges, suggesting the market views AMPH as a relatively stable option. The stock currently trades with a trailing P/E of 14.2, which is lower than the average analyst target price of $22.50.
Amphastar (AMPH) Cited as Safe-and-Steady Stock in Yahoo Analysis. A recent Yahoo Finance article highlighted Amphastar Pharmaceuticals as a 'safe-and-steady' stock worth researching further. This positive framing contrasts with other companies facing challenges, suggesting the market views AMPH as a relatively stable option. The stock currently trades with a trailing P/E of 14.2, which is lower than the average analyst target price of $22.50.